Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-06
DOI
10.1038/s41388-018-0407-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α
- (2016) Sangbin Lim et al. CANCER RESEARCH
- Cell polarity signaling in the plasticity of cancer cell invasiveness
- (2016) Aneta Gandalovičová et al. Oncotarget
- Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations
- (2015) K. Rycaj et al. CANCER RESEARCH
- Feedback regulation on PTEN/AKT pathway by the ER stress kinase PERK mediated by interaction with the Vault complex
- (2015) Wei Zhang et al. CELLULAR SIGNALLING
- Activated K-Ras, but Not H-Ras or N-Ras, Regulates Brain Neural Stem Cell Proliferation in a Raf/Rb-Dependent Manner
- (2015) R. Hugh F. Bender et al. STEM CELLS
- Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden
- (2014) Khalid Abubaker et al. BMC CANCER
- Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling
- (2014) Jacob R. Haling et al. CANCER CELL
- Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors
- (2014) Piro Lito et al. CANCER CELL
- Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients
- (2014) Zhou Bin et al. JOURNAL OF SURGICAL RESEARCH
- Rewiring cell polarity signaling in cancer
- (2014) R Halaoui et al. ONCOGENE
- Loss of p53 induces cell proliferation via Ras-independent activation of the Raf/Mek/Erk signaling pathway
- (2014) Matthias Drosten et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Cell polarity in morphogenesis and metastasis
- (2013) I. G. Macara et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Correction: Temporal Expression of Pelp1 during Proliferation and Osteogenic Differentiation of Rat Bone Marrow Mesenchymal Stem Cells
- (2013) Jing Wang et al. PLoS One
- Structure and T Cell Inhibition Properties of B7 Family Member, B7-H3
- (2013) Vladimir Vigdorovich et al. STRUCTURE
- B7-H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer
- (2012) Vibeke Anett Ingebrigtsen et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer stem cells and drug resistance: the potential of nanomedicine
- (2012) Serguei Vinogradov et al. Nanomedicine
- MVP expression in the prediction of clinical outcome of locally advanced oral squamous cell carcinoma patients treated with radiotherapy
- (2012) Luis Henríquez-Hernández et al. Radiation Oncology
- EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling
- (2011) Chun-Ju Chang et al. CANCER CELL
- Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells
- (2011) Piyush B. Gupta et al. CELL
- Costimulatory Protein 4IgB7H3 Drives the Malignant Phenotype of Glioblastoma by Mediating Immune Escape and Invasiveness
- (2011) D. Lemke et al. CLINICAL CANCER RESEARCH
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- B7-H3 Silencing Increases Paclitaxel Sensitivity by Abrogating Jak2/Stat3 Phosphorylation
- (2011) H. Liu et al. MOLECULAR CANCER THERAPEUTICS
- B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis
- (2010) Takaaki Arigami et al. ANNALS OF SURGERY
- Evaluation of B7-H3 Expression as a Biomarker of Biochemical Recurrence After Salvage Radiation Therapy for Recurrent Prostate Cancer
- (2010) Alexander S. Parker et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Cell Polarity in Motion: Redefining Mammary Tissue Organization Through EMT and Cell Polarity Transitions
- (2010) Nathan J. Godde et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas
- (2010) Xingxing Zang et al. MODERN PATHOLOGY
- MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors
- (2009) H. Xu et al. CANCER RESEARCH
- Expression of Immunosuppresive B7-H3 Ligand by Hormone-Treated Prostate Cancer Tumors and Metastases
- (2009) G. Chavin et al. CLINICAL CANCER RESEARCH
- B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction
- (2009) Judith Leitner et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Diagnosis value of serum B7-H3 expression in non-small cell lung cancer
- (2009) Guangbo Zhang et al. LUNG CANCER
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started